Pirfenidone and Paclitaxel Diminish Triple-Negative Breast Cancer
In a groundbreaking study on triple-negative breast cancer (TNBC), researchers have unveiled a promising therapeutic strategy that could reshape how ...
In a groundbreaking study on triple-negative breast cancer (TNBC), researchers have unveiled a promising therapeutic strategy that could reshape how ...
In a groundbreaking study set to redefine therapeutic strategies for aggressive breast cancers, researchers have unveiled the pivotal role of ...
In a groundbreaking advancement that could revolutionize treatment paradigms for triple-negative breast cancer (TNBC), researchers have unveiled a novel nanotechnology-based ...
In a groundbreaking development that could transform the therapeutic landscape of one of the most aggressive breast cancer subtypes, researchers ...
In a groundbreaking study poised to reshape the understanding of triple-negative breast cancer (TNBC), researchers have identified rare somatic variants ...
In a groundbreaking development poised to transform cancer research and treatment paradigms, a new study has unveiled compelling cytotoxic effects ...
A groundbreaking development in the treatment of HER2-positive breast cancer has emerged, heralding a new era in radioimmunotherapy that promises ...
In a groundbreaking study unveiled recently, researchers have illuminated the complex metabolic dependencies underpinning triple-negative breast cancer (TNBC), highlighting a ...
Triple-negative breast cancer (TNBC) remains one of the most challenging subtypes of breast cancer to treat effectively. Defined by the ...
In a groundbreaking study published in BMC Cancer, researchers have unveiled pivotal molecular distinctions between estrogen receptor-positive/progesterone receptor-positive (ER+/PR+) and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine